Improving Medication Adherence Through Graphically Enhanced Interventions in Acute Coronary Syndromes

NCT ID: NCT00399880

Last Updated: 2017-09-25

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 130 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2006-11-30
• Study Completion Date: 2008-08-31

Brief Summary

Coronary heart disease (CHD) is the leading cause of death in the United States. Most people who die from CHD die of a heart attack. Acute coronary syndrome (ACS) is a term that includes mild heart attacks, as well as other episodes of chest pain that may serve as a warning sign for an upcoming heart attack.

There are many medicines that can help prevent and treat ACS. However, at least 25% of patients don't take their medications as prescribed. When patients don't take their medications, we say they are noncompliant or nonadherent with the treatment.

The period following hospital discharge is a vulnerable time for many patients. Patients are often confused about what to do when they return home from the hospital. Many patients don't take their medications correctly, or they don't take them at all. Patients with poor literacy skills have more trouble than others, because it is harder for them to follow written instructions. Overall, about half of the adults in the U.S. have poor literacy skills. It is important to develop ways to help these adults manage their health better.

The purposes of this research project are 1) to learn more about the relationship between low literacy and medication adherence after hospital discharge, and 2) to test a strategy designed to help patients take their medicines more regularly. We will recruit consenting patients hospitalized with ACS. We will measure their literacy skills, ask questions about how they take their medicines, and measure other related factors like social support and self-efficacy. Patients will then be assigned to 1 of 2 groups. One group will receive only usual care at hospital discharge, which usually includes the nurse and physician briefly reviewing the medication prescriptions. The other group will receive an illustrated daily medication schedule and special, tailored counseling from a pharmacist at their time of discharge. About 1 week after patients leave the hospital we will contact them by phone to ask them questions about how they have been taking their medicines. We will get data from patients records for 6 months to see if the intervention had an impact on their medication compliance, blood pressure, cholesterol, and diabetes measurements.

If this study is successful, this simple strategy could be implemented by hospitals to improve medication compliance after discharge. This study will also provide more information about how patients' literacy skills affect their medication compliance.

Conditions

Acute Coronary Syndrome (ACS)

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: SINGLE

Study Groups

Health literacy intervention

Illustrated medication schedules, pill boxes, pharmacist counseling

Group Type: EXPERIMENTAL

Health literacy intervention

Intervention Type: BEHAVIORAL

Illustrated medication schedules, pill boxes, pharmacist counseling

Usual care

Group Type: NO_INTERVENTION

No interventions assigned to this group

Interventions

Health literacy intervention

Illustrated medication schedules, pill boxes, pharmacist counseling

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

• Present with acute chest pain or angina equivalent, lasting ≥ 10 minutes of suspected ischemic origin, within the previous 24 hours of presentation to the hospital.

PLUS

• Patient must have documented objective evidence of myocardial ischemia based on a or b:

1. EKG changes in ≥ 2 contiguous leads shown by:

• Transient (< 30 min) ST-segment elevation of ≥ 1.0mm

OR

• Transient or persistent ST-segment depression of ≥ 0.5mm (flat or downsloping at the J-point and at 80ms after the J-point)

OR

• Persistent T-wave inversion of ≥ 2.0mm

2. Abnormal elevation of cardiac enzymes

• Elevation of creating kinase (CK) and creatine kinase-myocardial band (CK-MB)

OR

• Elevation of troponin

Exclusion Criteria

• Previously enrolled in the study
• Police custody
• Corrected visual acuity worse than 20/60
• Lack of cooperation
• Severe hearing impairment
• Too ill to participate
• Unintelligible speech
• Age younger than 18 years
• Native language other than English
• Psychotic illness
• Caregiver administers all medications
• Delirium/severe dementia
• Does not fill prescriptions at Grady
• No regular telephone/address
• Not taking chronic medications prior to admission

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)

NIH

Sponsor Role: collaborator

American Society of Health-System Pharmacists Research and Education Foundation

OTHER

Sponsor Role: collaborator

Vanderbilt University Medical Center

OTHER

Sponsor Role: lead

Responsible Party

Sunil Kripalani

Associate Professor

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Sunil Kripalani, MD, MSc

Role: PRINCIPAL_INVESTIGATOR

Vanderbilt University Medical Center

Locations

Grady Memorial Hospital

Atlanta, Georgia, United States

Countries

United States

Other Identifiers

K23HL077597

Identifier Type: NIH

Identifier Source: secondary_id

View Link

00000116

Identifier Type: -

Identifier Source: org_study_id